University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

Recently, scientists have been able to explore gene circuitry in individual cells using methods that suppress particular ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...

Head and neck cancers rank fifth in cancer-related mortality and often begin in the tongue, throat, or neck before metastasizing.

Learn more about how a research team has successfully used CRISPR gene editing in the fight against cancer.

A new review in Engineering reveals that CRISPR technologies are revolutionizing regenerative medicine. Scientists from ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and ...